ロード中...
Bilateral acute anterior uveitis: a rare ocular side effect of erlotinib
Erlotinib used in the treatment of advanced non-small cell lung cancer (NSCLC) is a first-generation small-molecule tyrosine kinase inhibitor which reversibly inhibits the kinase domain of epithelial growth factor receptor (EGFR). The incidence of ocular toxicities as adverse effects (AE) of erlotin...
保存先:
| 出版年: | BMJ Case Rep |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6936442/ https://ncbi.nlm.nih.gov/pubmed/31843782 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-232868 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|